Skip Page Header

Home > Items where Subject is "B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone"

Up a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 96.


Medicines and Healthcare products Regulatory Agency. (2020) Opioids: risk of dependence and addiction. Drug Safety Update , 14 , (2) .

Ciapponi, Agustín (2020) Clinical question: For individuals with opiate use disorders, what are the effects of dihydrocodeine for detoxification? Cochrane Clinical Answers .

Vold, Jørn Henrik and Skurtveit, Svetlana and Aas, Christer and Chalabianloo, Fatemeh and Kloster, Pia Synnøve and Johansson, Kjell Arne and Fadnes, Lars Thore (2020) Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017. BMC Health Services Research , 20 , (352) , p. 352.

Wakeman, Sarah and Larochelle, Marc R and Ameli, Omid and Chaisson, Christine and McPheeters, Jeffrey Thomas and Crown, William H and Azocar, Francisca and Sanghavi, Darshak M (2020) Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open , 3 , (2: e1920622) .

Alexandridis, Apostolos A and Dasgupta, Nabarun and Ringwalt, Christopher L and Rosamond, Wayne D and Chelminski, Paul R and Marshall, Stephen W (2020) Association between opioid analgesic therapy and initiation of buprenorphine management: an analysis of prescription drug monitoring program data. PLoS ONE , 15 , (1 e0227350) , e0227350.

O'Connor, Aisling Máire and Cousins, Gráinne and Durand, Louise and Barry, Joe and Boland, Fiona (2020) Retention of patients in opioid substitution treatment: a systematic review. PLoS ONE , 15 , (5) , e0232086.

Clark, Brinton and Kai, Mari and Dix, Ryan and White, Jonathan and Rozenfeld, Yelena and Levy, Sheldon and Engstrom, Kathleen (2019) Association of a multimodal educational intervention for primary care physicians with prescriptions of buprenorphine for opioid use disorders. JAMA Network Open , 2 , (10) , e1913818.

Kennelly, Helen (2019) Opioid dependence: buprenorphine prolonged-release injection (Buvidal). Drugnet Ireland , Issue 70, Summer 2019 , pp. 26-27.

Strand, Maren Cecilie and Vindenes, Vigdis and Gjerde, Hallvard and Mørland, Jørg Gustav and Ramaekers, Johannes G (2019) A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers. British Journal of Clinical Pharmacology , 85 , (2) .

Drug and Alcohol Findings. (2018) Effectiveness of injectable extended-release naltrexone vs daily buprenorphine–naloxone for opioid dependence: a randomized clinical noninferiority trial. Drug and Alcohol Findings Research Analysis , (15 March 2018) .

Drug and Alcohol Findings. (2018) Drug treatment matrix cell A3: Interventions - medical treatment. Drug and Alcohol Findings Drug Treatment Matrix .

Hickman, Matthew and Steer, Colin and Tilling, Kate and Lim, Aaron G and Marsden, John and Millar, Tim and Strang, John and Telfer, Maggie and Vickerman, Peter and Macleod, John (2018) The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction , 113 , (8) .

Shanahan, Katie M and O'Grady, Michael J (2018) Advances in management of neonatal abstinence syndrome: what’s the score? Irish Medical Journal , 111 , (7) .

Burch, Jane and Magalhães, Pedro V (2017) Clinical question: How does buprenorphine compare with methadone or adrenergic agonists in people undergoing opioid withdrawal? Cochrane Clinical Answers .

Galvin, Brian (2017) European drug trends 2017. Drugnet Ireland , Issue 62, Summer 2017 , pp. 1-4.

Gowing, Linda and Ali, Robert and White, Jason M (2017) Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews , (2) .

Van Hout, Marie Claire and Hearne, Evelyn and Bergin, Michael (2017) Buprenorphine-naloxone in the treatment of codeine dependence: a scoping review of clinical case presentations. International Journal of Mental Health and Addiction , 15 , (1) , pp. 224-237.

Crowley, Des and Van Hout, Marie Claire (2017) Effectiveness of pharmacotherapies in increasing treatment retention and reducing opioid overdose death in individuals recently released from prison: a systematic review. Heroin Addiction and Related Clinical Problems , 19 , (2) .

Drug and Alcohol Findings. (2016) Worth supplementing buprenorphine with therapy? Drug and Alcohol Findings Research Analysis , (13 December 2016) .

Galvin, Brian (2016) European drug trends 2016. Drugnet Ireland , Issue 58, Summer 2016 , pp. 12-13.

O'Neill, Derek (2016) Misuse and dependence on codeine-containing medicines. Drugnet Ireland , Issue 57, Spring 2016 , pp. 16-17.

Nielsen, Suzanne and Larance, Briony and Degenhardt, Louisa and Gowing, Linda and Kehler, Chyanne and Lintzeris, Nicholas (2016) Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database of Systematic Reviews , (5) .

Van Hout, Marie Claire and Delargy, Ide and Ryan, Gerry and Flanagan, Siobhan and Gallagher, Hugh (2016) Dependence on Over the Counter (OTC) codeine containing analgesics: treatment and recovery with buprenorphine naloxone. International Journal of Mental Health and Addiction , 14 , (5) , pp. 873-883.

Magalhães, Pedro V (2015) Clinical question: What are the benefits and harms of buprenorphine maintenance versus placebo or methadone maintenance in people with opioid dependence? Cochrane Clinical Answers .

Mattick, Richard P and Breen, Courtney and Kimber, Jo and Davoli, Marina (2014) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews , (2) .

Lyons, Suzi (2013) Suboxone feasibility study evaluated. Drugnet Ireland , Issue 47, Autumn 2013 , pp. 19-22.

Lyons, Suzi (2013) Proposed regulatory framework for buprenorphine/naloxone products in Ireland. Drugnet Ireland , Issue 47, Autumn 2013 , pp. 22-23.

Drug and Alcohol Findings. (2013) Effectiveness Bank Bulletin [Effect of buprenorphine dose on treatment outcome]. Effectiveness Bank Bulletin , 15 Jul .

Drug and Alcohol Findings. (2013) Effectiveness Bank Bulletin. [Prison health care]. Effectiveness Bank Bulletin , 11 Jun .

Galvin, Brian (2013) Monitoring centre report reveals latest drug trends in Europe. Drugnet Ireland , Issue 44, Winter 2012 , pp. 4-5.

Lyons, Suzi (2012) Study findings on opiate substitution programme for adolescents. Drugnet Ireland , Issue 41, Spring 2012 , pp. 14-15.

Amass, Leslie and Pukeleviciene, Vilma and Subata, Emilis and Almeida, Antonio Rocha and Pieri, Maria Chiara Pieri and D'Egidio, Pietro and Stankova, Zdenka and Costa, Antonio and Smyth, Bobby P and Sakoman, Slavko and Wei, Yan and Strang, John (2012) A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals. Addiction , 107 , (1) , pp. 142-151.

Smyth, Bobby P and Fagan, John and Kernan, Kathy (2012) Outcome of heroin-dependent adolescents presenting for opiate substitution treatment. Journal of Substance Abuse Treatment , 42 , (1) , pp. 35-44.

Fagan, John and Keenan, Eamon (2008) Neonatal outcome following buprenorphine maintenance for opiate dependency. Irish Journal of Psychological Medicine , 25 , (4) , pp. 141-144.

Long, Jean (2007) Suboxone licensed in Europe. Drugnet Ireland , Issue 22, Summer 2007 , p. 25.

Long, Jean (2006) Buprenorphine - increasing choice for patients and doctors. Drugnet Ireland , Issue 17, Spring 2006 , pp. 19-20.

Lynn, Ena (2005) Management of Drug Users in the Primary Care Setting Conference. Drugnet Ireland , Issue 14, Summer 2005 , pp. 19-20.

O'Connor, JJ and Moloney, Eamonn and Travers, Raymond and Campbell, Aisling (1988) Buprenorphine abuse among opiate addicts. British Journal of Addiction , 83 , (9) , pp. 1085-1087.


[Medical Independent] , Lynch, David HSE reaches agreement with company to allow increased access to suboxone. (04 Oct 2018)

[Evening Echo] Merchants Quay Ireland welcomes move to widen use of suboxone in drug addiction treatment. (28 Apr 2018)

[Medical Independent] , Lynch, David Negotiations for wider availability of suboxone in ‘advanced stages’. (26 Apr 2018)

[Department of Health] Misuse of Drugs (supervision of prescription and supply of methadone and medicinal products containing buprenorphine authorised for opioid substitution treatment) regulations 2017 SI No. 522 of 2017. (28 Nov 2017)

[Medical Independent] , Lynch, David A new Minister, a new policy? (09 Jun 2016)

[Irish Examiner] , Baker, Noel Methadone alternative on the cards according to HSE. (03 Jan 2016)

National Institute on Drug Abuse. [NIDA] Buprenorphine treatment in pregnancy: less distress to babies. (09 Dec 2010)


Substance Abuse and Mental Health Services Administration. (2020) National survey on drug use and health (NSDUH). Rockville, MD: Substance Abuse and Mental Health Services Administration.

Canadian Centre on Substance Use and Addiction. (2020) Prescription opioids: Canadian drug summary. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.

Seele, Dale W and Becker, Sara J and Danko, Kristin J and Balk, Ethan M and Saldanha, Ian J and Adam, Gaelen P and Bagley, Sarah M and Friedman, Catherine and Spirito, Anthony and Scott, Kelli and Ntzani, Evangelia E and Saeed, Iman and Smith, Bryant and Popp, Jonah and Trikalinos, Thomas A (2020) Interventions for substance use disorders in adolescents: a systematic review. Rockville, MD: Agency for Healthcare Research and Quality.

Substance Abuse and Mental Health Services Administration. (2020) TIP 63: Medications for opioid use disorder – introduction to medications for opioid use disorder treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration.

Halliday, Kate, ed. Lintzeris, Nicholas and Dunlop, Adrian and Finch, Emily and Parsons, Graham and Hard, Bernadette and Brinksman, Steve (2020) UK Clinical guidelines for use of depot buprenorphine (Buvidal®) in the treatment of opioid dependence. London: SMMGP.

Harnedy, Norma and Kee, Jim and Cotter, Blaithin and Johnston, Helen and Egan, Mary (2020) Letter 1:. Urgent communication regarding OST patients. Dublin: Health Service Executive.

Sullivan, Tom and Voce, Isabella (2020) The social supply of pharmaceutical opioids. Canberra: Australian Institute of Criminology.

National Institute for Health and Care Excellence. (2019) Opioid dependence: buprenorphine prolonged release injection (Buvidal). London: NICE.

Dolan, Kate and Mehrjerdi, Zahra Alam (2015) Medication-assisted treatment of opioid dependence information toolkit. Sydney: Australian National Council on Drugs.

Gisev, Natasha and Larney, Sarah and Kimber, Jo and Burns, Lucy and Weatherburn, Don and Gibson, Amy and Dobbins, Tim and Mattick, Richard and Butler, Tony and Degenhardt, Louisa (2014) Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study. Sydney: National Drug and Alcohol Research Centre.

Create Consultancy. Fitzgerald, Niamh (2013) Evaluation of suboxone feasibility study in Ireland. Dublin: Department of Health.

Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence. (2011) Recommendations of the Expert Group on the Regulatory Framework for products containing buprenorphine / naloxone and buprenorphine-only for the treatment of opioid dependence. Dublin: Department of Health.

(2011) Suboxone for short-term detoxification: a review of the clinical evidence. Ottowa: Canadian Agency for Drugs and Technologies in Health.

Handford, Curtis and Kahan, Meldon and Srivastava, Anita and Cirone, Sharon and Palda, Valerie (2011) Buprenorphine/Naloxone for opioid dependence: clinical practice guideline. Toronto: Centre for Addiction and Mental health.

Health Service Executive. Social Inclusion Unit. Farrell, Michael and Barry, Joseph (2010) The introduction of the opioid treatment protocol. Dublin: Health Service Executive.

NIDA-SAMHSA Blending Initiative. (2010) Buprenorphine treatment for young adults. Bethesda, MD: NIDA-SAMHSA Blending Initiative.

NIDA-SAMHSA Blending Initiative. (2010) Short-term opioid withdrawal using buprenorphine: findings and strategies from a NIDA Clinical Trials Network (CTN) study. Bethesda, MD: NIDA-SAMHSA Blending Initiative.

Center for Substance Abuse Treatment. (2009) Buprenorphine: a guide for nurses. Rockville, MD: Substance Abuse and Mental Health Services Administration.

National Institute for Health and Clinical Excellence. (2007) Methadone and buprenorphine for the management of opioid dependence. London: NICE.

European Monitoring Centre for Drugs and Drug Addiction. (2005) European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) annual report 2005: selected issues. Luxembourg: Office for Official Publications of the European Communities.

Health Research Board. Drugs Misuse Research Division. (2004) 2004 National Report to the EMCDDA by the Reitox National Focal Point. Ireland. New developments, trends and in-depth information on selected issues. Dublin: Health Research Board.

RCGP Drug & Alcohol Misuse Training Programme, RCGP Sex, Drugs and HIV Task Group, SMMGP. (2004) Guidance for the use of buprenorphine for the treatment of opioid dependence in primary care. London: Royal College of General Practitioners.

Center for Substance Abuse Treatment. (2004) Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration.

McElrath, Karen (2003) Review of research on substitute prescribing for opiate dependence and implications for Northern Ireland. Belfast: Department of Health, Social Services and Public Safety.

National Medicines Information Centre. (2002) Report to the National Advisory Committee on Drugs on the use of buprenorphine as an intervention in the treatment of Opiate Dependence Syndrome. Dublin: Stationery Office.

Dail Debates

[Oireachtas] Dail Eireann debate. Written answer - medicinal products data [7108/19]. (12 Feb 2019)

[Oireachtas] Dail Eireann debate. Written answer 371- Drug treatment programmes [5593/17]. (07 Feb 2017)

[Oireachtas] Dail Eireann debate. Written answers 663, 664, 665, 666 - Drug treatment programmes [Buprenorphine-naloxone & services] [24091/16, 24092/16, 24094/16, 24093/16]. (21 Jul 2016)

[Oireachtas] Dail Eireann debate. Written answer 79 - Drug treatment programmes [Suboxone] [20967/16]. (12 Jun 2016)

[Oireachtas] Dail Eireann debate. Written answer 761 - medicinal products availability. [30578/15]. (22 Sep 2015)

[Oireachtas] Dail Eireann debate. Priority question 5 - National drugs rehabilitation framework [27728/15]. (09 Jul 2015)

[Oireachtas] Dail Eireann debate. Written answer 376 - Medicinal products availability [19728/15]. (19 May 2015)

[Oireachtas] Government's priorities for the year ahead: statements (resumed) (continued). (06 Mar 2014)

[Oireachtas] 205. Mr. Timmins asked the Minister for Health and Children if the drug Subutex is approved for the treatment of drug addicts; if not, if it is her intention to use or approve it. [13522/07]. (05 Apr 2007)

[Oireachtas] 139. Ms McManus asked the Minister for Health and Children further to the recent amendment by the Irish Medicines Board for the authorisation of Buprenorphine to be allowed to be prescribed by general practitioners with specialist training, the timeframe for her considerations of this authorisation; if there are obstacles;[35939/06]. (02 Nov 2006)


Miller, Peter M, ed. (2013) Interventions for Addiction. Volume 3 New York: Elsevier .

McKenna, Cailin R, ed. (2007) Trends in substance abuse research. New York: Nova Science Publishers .

Wechsburg, Wendee M and Kasten, Jennifer J (2007) Methadone maintenance treatment in the U.S. : a practical question and answer guide. New York: Springer .

Strain, Eric C and Stitzer, Maxine L, eds. (2006) The treatment of opioid dependence. Baltimore: Johns Hopkins University Press .

Verster, Annette and Buning, Ernst (2005) Buprenorphine: critical questions examined. Amsterdam: Euro-Methwork .

Waller, TA and Rumball, Daphne (2004) Treating drinkers and drug users in the community. Oxford: Blackwell Science .

Tober, Gillian and Strang, John, eds. (2003) Methadone matters: evolving community methadone treatment of opiate addiction. London: Martin Dunitz .

Gossop, Michael (2003) Drug addiction and its treatment. Oxford: Oxford University Press .

Kintz, Pascal and Marquet, Pierre, eds. (2002) Buprenorphine therapy of opiate addiction. Totowa: Humana Press .

Coombs, Robert S (2001) Addiction recovery tools: a practical handbook. Thousand Oaks Ca.: Sage .

Seivewright, Nicholas (2000) Community treatment of drug misuse: more than methadone. London: Cambridge University Press .

Ward, Jeff and Mattick, Richard P and Hall, Wayne, eds. (1998) Methadone maintenance treatment and other opioid replacement therapies. Sydney: Harwood Academic Publishers .

Bellenir, Karen, ed. (1996) Substance abuse sourcebook. Basic health-related information about the abuse of legal and illegal substance such as alcohol, tobacco, prescription drugs, marijuana, cocaine, and heroin; and including facts about substance abuse prevention strategies, intervention methods, treatment and recovery programs, and a section addressing the special problems related to substance abuse during pregnancy. Health Reference Series, v. 14 Detroit: Omingraphics .

Conference or Workshop Item

Harris, Simon (2017) Speech by Simon Harris TD , Minister for Health. In: Launch of Reducing harm, supporting recovery – A health led response to drug and alcohol use in Ireland 2017-2025., 17 July 2017, Dublin Castle.


Gupta, AK (2013) The implementation of an audit programme across drug treatment centre (DTC) pharmacies. MSc thesis, Royal College of Surgeons in Ireland.


UK Teratology Information Service. (2017) BUMPS: Best use of medicines in pregnancy - Buprenorphine. London: UK Teratology Information Service.

This list was generated on Mon Jan 25 03:30:15 2021 GMT.

We’d welcome your feedback!

Please participate in a very brief survey so we can improve your experience of using this website.

No Thanks . Don't take survey Take Survey . Survey opens in new tab